25 XP   0   0   10

Neximmune Inc
Buy, Hold or Sell?

Let's analyse Neximmune together

PenkeI guess you are interested in Neximmune Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Neximmune Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Neximmune Inc

I send you an email if I find something interesting about Neximmune Inc.

Quick analysis of Neximmune (30 sec.)










What can you expect buying and holding a share of Neximmune? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
$24.80
Expected worth in 1 year
$-133.23
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$-158.03
Return On Investment
-4,847.6%

For what price can you sell your share?

Current Price per Share
$3.26
Expected price per share
$1.25 - $9.4
How sure are you?
50%

1. Valuation of Neximmune (5 min.)




Live pricePrice per Share (EOD)

$3.26

Intrinsic Value Per Share

$-541.47 - $-643.82

Total Value Per Share

$-516.67 - $-619.03

2. Growth of Neximmune (5 min.)




Is Neximmune growing?

Current yearPrevious yearGrowGrow %
How rich?$32.3m$83.7m-$51.4m-159.3%

How much money is Neximmune making?

Current yearPrevious yearGrowGrow %
Making money$514.1m-$51.7m$565.9m110.1%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Neximmune (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#524 / 1010

Most Revenue
#775 / 1010

Most Profit
#9 / 1010

Most Efficient
#212 / 1010

What can you expect buying and holding a share of Neximmune? (5 min.)

Welcome investor! Neximmune's management wants to use your money to grow the business. In return you get a share of Neximmune.

What can you expect buying and holding a share of Neximmune?

First you should know what it really means to hold a share of Neximmune. And how you can make/lose money.

Speculation

The Price per Share of Neximmune is $3.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Neximmune.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Neximmune, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $24.80. Based on the TTM, the Book Value Change Per Share is $-39.51 per quarter. Based on the YOY, the Book Value Change Per Share is $76.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Neximmune.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-47.99-1,472.0%-47.99-1,472.0%-39.37-1,207.6%-26.43-810.7%-26.43-810.7%
Usd Book Value Change Per Share-39.51-1,211.9%-39.51-1,211.9%76.402,343.6%4.96152.1%4.96152.1%
Usd Dividend Per Share0.000.0%0.000.0%0.298.9%0.061.8%0.061.8%
Usd Total Gains Per Share-39.51-1,211.9%-39.51-1,211.9%76.692,352.5%5.02153.9%5.02153.9%
Usd Price Per Share0.24-0.24-4.61-0.97-0.97-
Price to Earnings Ratio-0.01--0.01--0.12--0.02--0.02-
Price-to-Total Gains Ratio-0.01--0.01-0.06-0.03-0.03-
Price to Book Ratio0.01-0.01-0.07-0.02-0.02-
Price-to-Total Gains Ratio-0.01--0.01-0.06-0.03-0.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.26
Number of shares306
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.06
Usd Book Value Change Per Share-39.514.96
Usd Total Gains Per Share-39.515.02
Gains per Quarter (306 shares)-12,089.501,535.41
Gains per Year (306 shares)-48,358.006,141.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-48358-483687160716132
20-96716-967261421214112274
30-145074-1450842131821218416
40-193432-1934422842428324558
50-241790-2418003553035330700
60-290148-2901584263642436842
70-338506-3385164974249542984
80-386864-3868745684856549126
90-435222-4352326395463655268
100-483580-4835907106070761410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.05.00.00.0%0.05.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.04.020.0%1.00.04.020.0%1.00.04.020.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%

Fundamentals of Neximmune

About Neximmune Inc

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. The company was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

Fundamental data was last updated by Penke on 2024-04-11 15:46:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Neximmune Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Neximmune earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Neximmune to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Neximmune Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y--449.1%+449.1%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Neximmune is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Neximmune to the Biotechnology industry mean.
  • 1,194.1% Return on Assets means that Neximmune generated $11.94 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Neximmune Inc:

  • The MRQ is 1,194.1%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 1,194.1%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ1,194.1%TTM1,194.1%0.0%
TTM1,194.1%YOY-56.8%+1,251.0%
TTM1,194.1%5Y123.7%+1,070.4%
5Y123.7%10Y123.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1,194.1%-13.3%+1,207.4%
TTM1,194.1%-12.8%+1,206.9%
YOY-56.8%-11.7%-45.1%
5Y123.7%-13.9%+137.6%
10Y123.7%-15.7%+139.4%
1.1.3. Return on Equity

Shows how efficient Neximmune is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Neximmune to the Biotechnology industry mean.
  • 1,591.9% Return on Equity means Neximmune generated $15.92 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Neximmune Inc:

  • The MRQ is 1,591.9%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 1,591.9%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ1,591.9%TTM1,591.9%0.0%
TTM1,591.9%YOY-61.8%+1,653.7%
TTM1,591.9%5Y244.0%+1,347.9%
5Y244.0%10Y244.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1,591.9%-16.9%+1,608.8%
TTM1,591.9%-16.1%+1,608.0%
YOY-61.8%-15.1%-46.7%
5Y244.0%-19.3%+263.3%
10Y244.0%-20.2%+264.2%

1.2. Operating Efficiency of Neximmune Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Neximmune is operating .

  • Measures how much profit Neximmune makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Neximmune to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Neximmune Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y--632.4%+632.4%
1.2.2. Operating Ratio

Measures how efficient Neximmune is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Neximmune Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y-5.739-5.739
10Y-7.876-7.876

1.3. Liquidity of Neximmune Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Neximmune is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.62 means the company has $3.62 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Neximmune Inc:

  • The MRQ is 3.616. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.616. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.616TTM3.6160.000
TTM3.616YOY11.957-8.341
TTM3.6165Y4.728-1.112
5Y4.72810Y4.7280.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6163.890-0.274
TTM3.6164.173-0.557
YOY11.9575.344+6.613
5Y4.7286.126-1.398
10Y4.7286.448-1.720
1.3.2. Quick Ratio

Measures if Neximmune is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Neximmune to the Biotechnology industry mean.
  • A Quick Ratio of 3.36 means the company can pay off $3.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Neximmune Inc:

  • The MRQ is 3.360. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.360. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.360TTM3.3600.000
TTM3.360YOY18.475-15.115
TTM3.3605Y6.724-3.365
5Y6.72410Y6.7240.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3603.514-0.154
TTM3.3603.998-0.638
YOY18.4755.380+13.095
5Y6.7246.105+0.619
10Y6.7246.404+0.320

1.4. Solvency of Neximmune Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Neximmune assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Neximmune to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.25 means that Neximmune assets are financed with 25.0% credit (debt) and the remaining percentage (100% - 25.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Neximmune Inc:

  • The MRQ is 0.250. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.250. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.250TTM0.2500.000
TTM0.250YOY0.080+0.170
TTM0.2505Y0.637-0.387
5Y0.63710Y0.6370.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2500.339-0.089
TTM0.2500.336-0.086
YOY0.0800.271-0.191
5Y0.6370.366+0.271
10Y0.6370.389+0.248
1.4.2. Debt to Equity Ratio

Measures if Neximmune is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Neximmune to the Biotechnology industry mean.
  • A Debt to Equity ratio of 33.3% means that company has $0.33 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Neximmune Inc:

  • The MRQ is 0.333. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.333. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.333TTM0.3330.000
TTM0.333YOY0.087+0.246
TTM0.3335Y0.204+0.129
5Y0.20410Y0.2040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3330.388-0.055
TTM0.3330.402-0.069
YOY0.0870.335-0.248
5Y0.2040.426-0.222
10Y0.2040.461-0.257

2. Market Valuation of Neximmune Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Neximmune generates.

  • Above 15 is considered overpriced but always compare Neximmune to the Biotechnology industry mean.
  • A PE ratio of -0.01 means the investor is paying $-0.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Neximmune Inc:

  • The EOD is -0.068. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.005. Based on the earnings, the company is expensive. -2
  • The TTM is -0.005. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.068MRQ-0.005-0.063
MRQ-0.005TTM-0.0050.000
TTM-0.005YOY-0.117+0.112
TTM-0.0055Y-0.024+0.019
5Y-0.02410Y-0.0240.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.068-2.264+2.196
MRQ-0.005-2.629+2.624
TTM-0.005-2.680+2.675
YOY-0.117-4.145+4.028
5Y-0.024-6.257+6.233
10Y-0.024-6.254+6.230
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Neximmune Inc:

  • The EOD is -0.081. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.006. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.006. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.081MRQ-0.006-0.075
MRQ-0.006TTM-0.0060.000
TTM-0.006YOY-0.125+0.119
TTM-0.0065Y-0.026+0.020
5Y-0.02610Y-0.0260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.081-2.973+2.892
MRQ-0.006-3.333+3.327
TTM-0.006-3.553+3.547
YOY-0.125-5.605+5.480
5Y-0.026-8.376+8.350
10Y-0.026-8.865+8.839
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Neximmune is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.01 means the investor is paying $0.01 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Neximmune Inc:

  • The EOD is 0.131. Based on the equity, the company is cheap. +2
  • The MRQ is 0.010. Based on the equity, the company is cheap. +2
  • The TTM is 0.010. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.131MRQ0.010+0.122
MRQ0.010TTM0.0100.000
TTM0.010YOY0.072-0.062
TTM0.0105Y0.016-0.006
5Y0.01610Y0.0160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.1311.896-1.765
MRQ0.0102.115-2.105
TTM0.0102.093-2.083
YOY0.0722.884-2.812
5Y0.0163.542-3.526
10Y0.0163.916-3.900
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Neximmune Inc.

3.1. Institutions holding Neximmune Inc

Institutions are holding 7.972% of the shares of Neximmune Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Slate Path Capital LP2.84060.001836999369990
2023-12-31Adage Capital Partners Gp LLC2.46090.000232054320540
2023-12-31EPIQ Capital Group, LLC1.19950.015815624156240
2023-12-31PNC Financial Services Group Inc0.9704012640126400
2023-12-31Comerica Bank0.2503256-1-0.0307
2023-12-31Tower Research Capital LLC0.13830.0001180118010
2023-12-31Royal Bank of Canada0.08040104710470
2023-12-31Morgan Stanley - Brokerage Accounts0.0013017170
2023-12-31BlackRock Inc0.0011014140
2023-12-31Wells Fargo & Co0.00040550
2023-12-31UBS Group AG0.00010110
2023-09-30JANE STREET GROUP, LLC000-44969-100
2023-12-31Caprock Group Inc000-4139-100
2023-09-30Envestnet Asset Management Inc000-81421-100
2023-09-30Davenport & Company LLC000-26000-100
2023-09-30HRT FINANCIAL LLC000-41958-100
Total 7.9430.0179103458-98286-95.0%

3.2. Funds holding Neximmune Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.92210.0001120107704178.9131
2024-03-29Dimensional US Targeted Value ETF0.50890.0004662800
2024-02-29Fidelity Extended Market Index0.24460.00013186-15-0.4686
2024-02-29DFA US Small Cap I0.08870.0001115511550
2024-02-29Fidelity Nasdaq Composite Index0.0366047700
2023-09-30BlackRock Extended Mkt Composite0.0011036000
2024-02-29Fidelity Series Total Market Index0.0202026300
2024-02-29Fidelity Total Market Index0.02026000
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.019024800
2023-12-31Northern Trust Extended Eq Market Idx0.0174022600
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0174022600
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0153019900
2024-03-31State St US Extended Mkt Indx NL Cl C0.0086011200
2023-12-31SSgA U.S. Extended Market Index Class I0.0086011200
2024-02-29Spartan Total Market Index Pool E0.0078010200
2024-02-29Spartan Extended Market Index Pool E0.00270351575
2023-12-31SSgA U.S. Total Market Index Strategy0.0025032-1-3.0303
2023-12-31NT US Market Cap Idx Fd - L0.002202900
2023-12-31Northern Trust Wilshire 50000.002202900
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00060800
Total 1.94650.000725697+8858+34.5%

3.3. Insider Transactions

Insiders are holding 21.802% of the shares of Neximmune Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-21Alan S RoemerSELL38332.16

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Neximmune Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---39.508-39.5080%76.402-152%4.960-897%4.960-897%
Book Value Per Share--24.79824.7980%64.307-61%17.253+44%17.253+44%
Current Ratio--3.6163.6160%11.957-70%4.728-24%4.728-24%
Debt To Asset Ratio--0.2500.2500%0.080+213%0.637-61%0.637-61%
Debt To Equity Ratio--0.3330.3330%0.087+284%0.204+63%0.204+63%
Dividend Per Share----0%0.290-100%0.058-100%0.058-100%
Eps---47.989-47.9890%-39.369-18%-26.430-45%-26.430-45%
Free Cash Flow Per Share---40.265-40.2650%-36.956-8%-23.051-43%-23.051-43%
Free Cash Flow To Equity Per Share---36.289-36.2890%58.926-162%3.381-1173%3.381-1173%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---643.824--------
Intrinsic Value_10Y_min---541.470--------
Intrinsic Value_1Y_max---39.663--------
Intrinsic Value_1Y_min---38.541--------
Intrinsic Value_3Y_max---138.112--------
Intrinsic Value_3Y_min---130.099--------
Intrinsic Value_5Y_max---259.397--------
Intrinsic Value_5Y_min---236.628--------
Market Cap4246215.200+93%316512.360316512.3600%6004617.200-95%1264225.912-75%1264225.912-75%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.131+93%0.0100.0100%0.072-86%0.016-40%0.016-40%
Pe Ratio-0.068-1242%-0.005-0.0050%-0.117+2212%-0.024+382%-0.024+382%
Price Per Share3.260+93%0.2430.2430%4.610-95%0.971-75%0.971-75%
Price To Free Cash Flow Ratio-0.081-1242%-0.006-0.0060%-0.125+1967%-0.026+333%-0.026+333%
Price To Total Gains Ratio-0.083-1242%-0.006-0.0060%0.060-110%0.027-123%0.027-123%
Quick Ratio--3.3603.3600%18.475-82%6.724-50%6.724-50%
Return On Assets--11.94111.9410%-0.568+105%1.237+865%1.237+865%
Return On Equity--15.91915.9190%-0.618+104%2.440+552%2.440+552%
Total Gains Per Share---39.508-39.5080%76.692-152%5.018-887%5.018-887%
Usd Book Value--32300484.00032300484.0000%83760667.000-61%24345700.400+33%24345700.400+33%
Usd Book Value Change Per Share---39.508-39.5080%76.402-152%4.960-897%4.960-897%
Usd Book Value Per Share--24.79824.7980%64.307-61%17.253+44%17.253+44%
Usd Dividend Per Share----0%0.290-100%0.058-100%0.058-100%
Usd Eps---47.989-47.9890%-39.369-18%-26.430-45%-26.430-45%
Usd Free Cash Flow---52446036.000-52446036.0000%-48135487.000-8%-32113729.600-39%-32113729.600-39%
Usd Free Cash Flow Per Share---40.265-40.2650%-36.956-8%-23.051-43%-23.051-43%
Usd Free Cash Flow To Equity Per Share---36.289-36.2890%58.926-162%3.381-1173%3.381-1173%
Usd Market Cap4246215.200+93%316512.360316512.3600%6004617.200-95%1264225.912-75%1264225.912-75%
Usd Price Per Share3.260+93%0.2430.2430%4.610-95%0.971-75%0.971-75%
Usd Profit--514183801.000514183801.0000%-51745427.000+110%79533245.200+547%79533245.200+547%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---39.508-39.5080%76.692-152%5.018-887%5.018-887%
 EOD+5 -3MRQTTM+0 -0YOY+5 -265Y+9 -2210Y+9 -22

4.2. Fundamental Score

Let's check the fundamental score of Neximmune Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.068
Price to Book Ratio (EOD)Between0-10.131
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.360
Current Ratio (MRQ)Greater than13.616
Debt to Asset Ratio (MRQ)Less than10.250
Debt to Equity Ratio (MRQ)Less than10.333
Return on Equity (MRQ)Greater than0.1515.919
Return on Assets (MRQ)Greater than0.0511.941
Total7/10 (70.0%)

4.3. Technical Score

Let's check the technical score of Neximmune Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.968
Ma 20Greater thanMa 504.106
Ma 50Greater thanMa 1005.630
Ma 100Greater thanMa 2006.042
OpenGreater thanClose3.480
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Net Income  -12,834-7,466-20,300-11,339-31,639-20,107-51,745565,929514,184



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets43,060
Total Liabilities10,759
Total Stockholder Equity32,300
 As reported
Total Liabilities 10,759
Total Stockholder Equity+ 32,300
Total Assets = 43,060

Assets

Total Assets43,060
Total Current Assets37,369
Long-term Assets5,691
Total Current Assets
Cash And Cash Equivalents 34,642
Net Receivables 74
Inventory -19
Other Current Assets 2,671
Total Current Assets  (as reported)37,369
Total Current Assets  (calculated)37,369
+/-0
Long-term Assets
Property Plant Equipment 5,426
Long-term Assets Other 265
Long-term Assets  (as reported)5,691
Long-term Assets  (calculated)5,691
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,334
Long-term Liabilities426
Total Stockholder Equity32,300
Total Current Liabilities
Short-term Debt 599
Accounts payable 2,377
Other Current Liabilities 7,357
Total Current Liabilities  (as reported)10,334
Total Current Liabilities  (calculated)10,334
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt426
Long-term Liabilities  (as reported)426
Long-term Liabilities  (calculated)426
+/-0
Total Stockholder Equity
Common Stock3
Retained Earnings -190,250
Other Stockholders Equity 222,548
Total Stockholder Equity (as reported)32,300
Total Stockholder Equity (calculated)32,300
+/-0
Other
Capital Stock3
Cash and Short Term Investments 34,642
Common Stock Shares Outstanding 962
Liabilities and Stockholders Equity 43,060
Net Debt -33,618
Net Invested Capital 32,300
Net Tangible Assets 32,300
Net Working Capital 27,035
Property Plant and Equipment Gross 5,426
Short Long Term Debt Total 1,025



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
14,142
13,718
11,301
91,032
43,060
43,06091,03211,30113,71814,142
   > Total Current Assets 
12,334
11,037
8,392
86,281
37,369
37,36986,2818,39211,03712,334
       Cash And Cash Equivalents 
426
9,129
5,031
30,326
34,642
34,64230,3265,0319,129426
       Short-term Investments 
11,634
1,007
0
51,492
0
051,49201,00711,634
       Net Receivables 
74
6
0
0
74
7400674
       Other Current Assets 
200
833
79
99
2,671
2,6719979833200
   > Long-term Assets 
1,809
2,682
2,909
4,751
5,691
5,6914,7512,9092,6821,809
       Property Plant Equipment 
1,695
2,578
2,885
4,427
5,426
5,4264,4272,8852,5781,695
       Other Assets 
114
104
23
91,032
0
091,03223104114
> Total Liabilities 
3,332
3,107
27,055
7,271
10,759
10,7597,27127,0553,1073,332
   > Total Current Liabilities 
3,003
3,025
27,027
7,216
10,334
10,3347,21627,0273,0253,003
       Short-term Debt 
0
0
19,118
0
599
599019,11800
       Short Long Term Debt 
0
0
19,118
0
0
0019,11800
       Accounts payable 
861
1,172
2,760
1,045
2,377
2,3771,0452,7601,172861
       Other Current Liabilities 
2,142
1,853
2,546
6,171
7,357
7,3576,1712,5461,8532,142
   > Long-term Liabilities 
329
82
28
56
426
426562882329
       Other Liabilities 
329
82
28
56
0
0562882329
> Total Stockholder Equity
10,810
10,611
-15,754
83,761
32,300
32,30083,761-15,75410,61110,810
   Common Stock
0
0
0
2
3
32000
   Retained Earnings Total Equity00000
   Accumulated Other Comprehensive Income 
-30
1
0
3
0
0301-30
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 
2,962
4,706
8,207
-90,820,617
222,548
222,548-90,820,6178,2074,7062,962



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-44,853
Operating Income-44,853-44,853
 
Operating Expense (+$)
Research Development30,736
Selling General Administrative14,117
Selling And Marketing Expenses-
Operating Expense44,85344,853
 
Net Interest Income (+$)
Interest Income973
Interest Expense--
Other Finance Cost-0
Net Interest Income973
 
Pretax Income (+$)
Operating Income-44,853
Net Interest Income973
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-43,879-44,854
EBIT - interestExpense = 0
-43,879
-43,879
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--43,879
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-43,879
Tax Provision--
Net Income From Continuing Ops-43,879-43,879
Net Income-43,879
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net1-973
 

Technical Analysis of Neximmune
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Neximmune. The general trend of Neximmune is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Neximmune's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Neximmune Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.84 < 5.5 < 9.4.

The bearish price targets are: 3.01 > 2.072 > 1.25.

Tweet this
Neximmune Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Neximmune Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Neximmune Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Neximmune Inc. The current macd is -0.69869717.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Neximmune price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Neximmune. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Neximmune price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Neximmune Inc Daily Moving Average Convergence/Divergence (MACD) ChartNeximmune Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Neximmune Inc. The current adx is 25.12.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Neximmune shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Neximmune Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Neximmune Inc. The current sar is 3.044848.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Neximmune Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Neximmune Inc. The current rsi is 32.97. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Neximmune Inc Daily Relative Strength Index (RSI) ChartNeximmune Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Neximmune Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Neximmune price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Neximmune Inc Daily Stochastic Oscillator ChartNeximmune Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Neximmune Inc. The current cci is -76.34740518.

Neximmune Inc Daily Commodity Channel Index (CCI) ChartNeximmune Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Neximmune Inc. The current cmo is -35.71906087.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Neximmune Inc Daily Chande Momentum Oscillator (CMO) ChartNeximmune Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Neximmune Inc. The current willr is -87.04663212.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Neximmune Inc Daily Williams %R ChartNeximmune Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Neximmune Inc.

Neximmune Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Neximmune Inc. The current atr is 0.50848579.

Neximmune Inc Daily Average True Range (ATR) ChartNeximmune Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Neximmune Inc. The current obv is 138,021,643.

Neximmune Inc Daily On-Balance Volume (OBV) ChartNeximmune Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Neximmune Inc. The current mfi is 27.45.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Neximmune Inc Daily Money Flow Index (MFI) ChartNeximmune Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Neximmune Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Neximmune Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Neximmune Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.968
Ma 20Greater thanMa 504.106
Ma 50Greater thanMa 1005.630
Ma 100Greater thanMa 2006.042
OpenGreater thanClose3.480
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Neximmune with someone you think should read this too:
  • Are you bullish or bearish on Neximmune? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Neximmune? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Neximmune Inc

I send you an email if I find something interesting about Neximmune Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Neximmune Inc.

Receive notifications about Neximmune Inc in your mailbox!